Biased exon/intron distribution of cryptic and de novo 3′ splice sites

We compiled sequences of previously published aberrant 3′ splice sites (3′ss) that were generated by mutations in human disease genes. Cryptic 3′ss, defined here as those resulting from a mutation of the 3′YAG consensus, were more frequent in exons than in introns. They clustered in ∼20 nt region adjacent to authentic 3′ss, suggesting that their under-representation in introns is due to a depletion of AG dinucleotides in the polypyrimidine tract (PPT). In contrast, most aberrant 3′ss that were induced by mutations outside the 3′YAG consensus (designated ‘de novo’) were in introns. The activation of intronic de novo 3′ss was largely due to AG-creating mutations in the PPT. In contrast, exonic de novo 3′ss were more often induced by mutations improving the PPT, branchpoint sequence (BPS) or distant auxiliary signals, rather than by direct AG creation. The Shapiro–Senapathy matrix scores had a good prognostic value for cryptic, but not de novo 3′ss. Finally, AG-creating mutations in the PPT that produced aberrant 3′ss upstream of the predicted BPS in vivo shared a similar ‘BPS-new AG’ distance. Reduction of this distance and/or the strength of the new AG PPT in splicing reporter pre-mRNAs improved utilization of authentic 3′ss, suggesting that AG-creating mutations that are located closer to the BPS and are preceded by weaker PPT may result in less severe splicing defects.

[1]  L. Ala‐Kokko,et al.  Analysis of the COL1A1 and COL1A2 genes by PCR amplification and scanning by conformation-sensitive gel electrophoresis identifies only COL1A1 mutations in 15 patients with osteogenesis imperfecta type I: identification of common sequences of null-allele mutations. , 1998, American journal of human genetics.

[2]  M. Vidaud,et al.  Molecular characterization of cystic fibrosis: 16 novel mutations identified by analysis of the whole cystic fibrosis conductance transmembrane regulator (CFTR) coding regions and splice site junctions. , 1992, Genomics.

[3]  G. Ast,et al.  Human-mouse comparative analysis reveals that branch-site plasticity contributes to splicing regulation. , 2005, Human molecular genetics.

[4]  J. Trapman,et al.  Molecular analysis of the androgen-receptor gene in a family with receptor-positive partial androgen insensitivity: an unusual type of intronic mutation. , 1997, American journal of human genetics.

[5]  K. Mayer,et al.  Three novel types of splicing aberrations in the tuberous sclerosis TSC2 gene caused by mutations apart from splice consensus sequences. , 2000, Biochimica et biophysica acta.

[6]  S. Ghosh,et al.  A novel intronic mutation results in the use of a cryptic splice acceptor site within the coding region of UGT1A1, causing Crigler-Najjar syndrome type 1. , 2002, Molecular genetics and metabolism.

[7]  D. Prockop,et al.  A-2-->G transition at the 3' acceptor splice site of IVS17 characterizes the COL2A1 gene mutation in the original Stickler syndrome kindred. , 1996, American journal of medical genetics.

[8]  M. Hentze,et al.  Abnormally spliced b-globin mRNAs : a single point mutation generates transcripts sensitive and insensitive to nonsense-mediated mRNA decay , 2002 .

[9]  W. Engel,et al.  Three novel SALL1 mutations extend the mutational spectrum in Townes-Brocks syndrome , 1999, Journal of medical genetics.

[10]  T. Dryja,et al.  Recessive mutations in the gene encoding the tubby-like protein TULP1 in patients with Retinitis pigmentosa , 1998, Nature Genetics.

[11]  J. Valcárcel,et al.  Dual Function for U2AF35 in AG-Dependent Pre-mRNA Splicing , 2001, Molecular and Cellular Biology.

[12]  W. Fenton,et al.  Identification of RNA splicing errors resulting in human ornithine transcarbamylase deficiency. , 1991, American journal of human genetics.

[13]  R. Flavell,et al.  β + Thalassemia: Aberrant splicing results from a single point mutation in an intron , 1981, Cell.

[14]  John M. Maris,et al.  Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia , 1999, Nature Genetics.

[15]  O. Blumenfeld,et al.  Alternative splicing of a novel glycophorin allele GPHe(GL) generates two protein isoforms in the human erythrocyte membrane. , 1997, Blood.

[16]  J. Beggs,et al.  Extensive interactions of PRP8 protein with the 5′ and 3′ splice sites during splicing suggest a role in stabilization of exon alignment by U5 snRNA. , 1995, The EMBO journal.

[17]  J. G. Patton,et al.  Functional analysis of the polypyrimidine tract in pre-mRNA splicing. , 1997, Nucleic acids research.

[18]  W. Kuo,et al.  ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency. , 1994, Science.

[19]  H. Rabb,et al.  Genetic cause of leukocyte adhesion molecule deficiency. Abnormal splicing and a missense mutation in a conserved region of CD18 impair cell surface expression of beta 2 integrins. , 1992, The Journal of biological chemistry.

[20]  J. Laporte,et al.  Confirmation of prenatal diagnosis results of X‐linked recessive myotubular myopathy by mutational screening, and description of three new mutations in the MTM1 gene , 1998, Human mutation.

[21]  J. Varley,et al.  Characterization of germline TP53 splicing mutations and their genetic and functional analysis , 2001, Oncogene.

[22]  C. Heizmann,et al.  Identification of mutations causing 6‐pyruvoyl‐tetrahydropterin synthase deficiency in four Italian families , 1997, Human mutation.

[23]  P. A. Biro,et al.  Base substitution in an intervening sequence of a beta+-thalassemic human globin gene. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Bouck,et al.  Genetic selection for balanced retroviral splicing: novel regulation involving the second step can be mediated by transitions in the polypyrimidine tract , 1995, Molecular and cellular biology.

[25]  R. Spritz,et al.  Frequent intragenic deletion of the P gene in Tanzanian patients with type II oculocutaneous albinism (OCA2). , 1995, American journal of human genetics.

[26]  F. Baralle,et al.  Genetic studies on myeloperoxidase deficiency in Italy. , 2004, Japanese journal of infectious diseases.

[27]  R. Wevers,et al.  A branch site mutation leading to aberrant splicing of the human tyrosine hydroxylase gene in a child with a severe extrapyramidal movement disorder , 2000, Annals of human genetics.

[28]  I. Vauhkonen,et al.  Mutations in the cardiac myosin-binding protein C gene are the predominant cause of familial hypertrophic cardiomyopathy in eastern Finland , 2002, Journal of Molecular Medicine.

[29]  T. Funahashi,et al.  A novel point mutation in a splice acceptor site of intron 1 of the human low density lipoprotein receptor gene which causes severe hypercholesterolemia: An unexpected absence of exon skipping , 1998, Human mutation.

[30]  B. Coller,et al.  The molecular genetic basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[31]  C. Pérez-Cerdá,et al.  A novel single-base substitution (380C>T) that activates a 5-base downstream cryptic splice-acceptor site within exon 5 in almost all transcripts in the human mitochondrial acetoacetyl-CoA thiolase gene. , 2001, Molecular genetics and metabolism.

[32]  W. Cole,et al.  COL5A1 Exon 14 Splice Acceptor Mutation Causes a Functional Null Allele, Haploinsufficiency of α1(V) and Abnormal Heterotypic Interstitial Fibrils in Ehlers-Danlos Syndrome II* , 2001, The Journal of Biological Chemistry.

[33]  Christopher W. J. Smith,et al.  Scanning and competition between AGs are involved in 3' splice site selection in mammalian introns , 1993, Molecular and cellular biology.

[34]  Marvin B. Shapiro,et al.  RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. , 1987, Nucleic acids research.

[35]  G. Deuschl,et al.  Two previously unrecognized splicing mutations of GCH1 in Dopa-responsive dystonia: exon skipping and one base insertion , 1997, Neurogenetics.

[36]  C. Burant,et al.  Congenital hypothyroidism due to mutations in the sodium/iodide symporter. Identification of a nonsense mutation producing a downstream cryptic 3' splice site. , 1998, The Journal of clinical investigation.

[37]  C. Patrosso,et al.  Organization of the human CD40L gene: implications for molecular defects in X chromosome-linked hyper-IgM syndrome and prenatal diagnosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[38]  T. Hennet,et al.  Clinical and molecular features of three patients with congenital disorders of glycosylation type Ih (CDG-Ih) (ALG8 deficiency) , 2004, Journal of Medical Genetics.

[39]  J. Vandesompele,et al.  Pathological splice mutations outside the invariant AG/GT splice sites of BRCA1 exon 5 increase alternative transcript levels in the 5′ end of the BRCA1 gene , 2002, Oncogene.

[40]  M. Claustres,et al.  Point mutations in the dystrophin gene: Evidence for frequent use of cryptic splice sites as a result of splicing defects , 1999, Human mutation.

[41]  C. Mathew,et al.  High frequency of large intragenic deletions in the Fanconi anemia group A gene. , 1999, American journal of human genetics.

[42]  W. Cole,et al.  A base substitution at the splice acceptor site of intron 5 of the COL1A2 gene activates a cryptic splice site within exon 6 and generates abnormal type I procollagen in a patient with Ehlers-Danlos syndrome type VII. , 1992, The Journal of biological chemistry.

[43]  F. Collins,et al.  Beta zero thalassemia caused by a base substitution that creates an alternative splice acceptor site in an intron. , 1986, The EMBO journal.

[44]  C. Schwartz,et al.  Multiple exon screening using restriction endonuclease fingerprinting (REF): Detection of six novel mutations in the L1 cell adhesion molecule (L1CAM) gene , 1998, Human mutation.

[45]  G. Pavlakis,et al.  The molecular basis of a familial apoE deficiency. An acceptor splice site mutation in the third intron of the deficient apoE gene. , 1987, The Journal of biological chemistry.

[46]  C. Glover,et al.  Gene expression profiling for hematopoietic cell culture , 2006 .

[47]  I. Tsukimoto,et al.  Frame shift mutation, exon skipping, and a two-codon deletion caused by splice site mutations account for pyruvate kinase deficiency. , 1997, Blood.

[48]  Y. Yazaki,et al.  Two aberrant splicings caused by mutations in the insulin receptor gene in cultured lymphocytes from a patient with Rabson-Mendenhall's syndrome. , 1998, The Journal of clinical investigation.

[49]  Peter G. Korning,et al.  Splice Site Prediction in Arabidopsis Thaliana Pre-mRNA by Combining Local and Global Sequence Information , 1996 .

[50]  J. Fraumeni,et al.  Novel p53 splice site mutations in three families with Li-Fraumeni syndrome , 2000, Oncogene.

[51]  Zhenhua Zhang,et al.  Distinct mechanisms lead to HPRT gene mutations in leukemic cells , 2004, Genes, chromosomes & cancer.

[52]  M. Mannens,et al.  The Human Chitotriosidase Gene NATURE OF INHERITED ENZYME DEFICIENCY* , 1998 .

[53]  F. Kramer,et al.  Identification of novel TP53 mutations in familial and sporadic cancer cases of German and Swiss origin. , 2004, Cancer genetics and cytogenetics.

[54]  J. Minna,et al.  Identification of intronic point mutations as an alternative mechanism for p53 inactivation in lung cancer. , 1990, The Journal of clinical investigation.

[55]  R. Reed,et al.  An Upstream AG Determines Whether a Downstream AG Is Selected during Catalytic Step II of Splicing , 2001, Molecular and Cellular Biology.

[56]  P. Mannucci,et al.  Missense or splicing mutation? The case of a fibrinogen Bbeta-chain mutation causing severe hypofibrinogenemia. , 2004, Blood.

[57]  I. Vořechovský,et al.  Identification of Splicing Silencers and Enhancers in Sense Alus: a Role for Pseudoacceptors in Splice Site Repression , 2005, Molecular and Cellular Biology.

[58]  R. Guigó,et al.  Are splicing mutations the most frequent cause of hereditary disease? , 2005, FEBS letters.

[59]  R. Weinshilboum,et al.  Human thiopurine methyltransferase pharmacogenetics. Kindred with a terminal exon splice junction mutation that results in loss of activity. , 1998, The Journal of clinical investigation.

[60]  M. Dyer,et al.  Clustering of missense mutations in the ataxia-telanglectasia gene in a sporadic T-cell leukaemia , 1997, Nature Genetics.

[61]  S. Thibodeau,et al.  Supravalvular aortic stenosis: a splice site mutation within the elastin gene results in reduced expression of two aberrantly spliced transcripts , 1999, Human Genetics.

[62]  R. Reed,et al.  Evidence that U5 snRNP recognizes the 3′ splice site for catalytic step II in mammals , 1997, The EMBO journal.

[63]  B. Dworniczak,et al.  Identification of four novel mutations in the factor VIII gene: Three missense mutations (E1875G, G2088S, I2185T) and a 2‐bp deletion (1780delTC) , 1998, Human mutation.

[64]  P. Huppke,et al.  Mutation spectrum in patients with Rett syndrome in the German population: Evidence of hot spot regions , 2001, Human mutation.

[65]  E. M. McCarthy,et al.  Characterization of an intron splice enhancer that regulates alternative splicing of human GH pre-mRNA. , 1998, Human molecular genetics.

[66]  S. Berget Exon Recognition in Vertebrate Splicing (*) , 1995, The Journal of Biological Chemistry.

[67]  V. Bataille,et al.  Gorlin syndrome: Identification of 4 novel germ‐line mutations of the human patched (PTCH) gene , 1998, Human mutation.

[68]  A. V. D. Eb,et al.  A presumed DNA helicase encoded by ERCC-3 is involved in the human repair disorders xeroderma pigmentosum and Cockayne's syndrome , 1990, Cell.

[69]  K. Nakai,et al.  Construction of a novel database containing aberrant splicing mutations of mammalian genes. , 1994, Gene.

[70]  M. Morita,et al.  A novel mutation in the spastin gene in a family with spastic paraplegia , 2002, Neuroscience Letters.

[71]  A. Ruvinsky,et al.  Natural Selection Affects Frequencies of AG and GT Dinucleotides at the 5′ and 3′ Ends of Exons , 2004, Genetics.

[72]  E. Lyon,et al.  Implications of a novel cryptic splice site in the BRCA1 gene. , 1998, American journal of medical genetics.

[73]  Ludwine Messiaen,et al.  Differentiating pathogenic mutations from polymorphic alterations in the splice sites of BRCA1 and BRCA2 , 2003, Genes, chromosomes & cancer.

[74]  I. Mattaj,et al.  The carboxyl terminus of vertebrate poly(A) polymerase interacts with U2AF 65 to couple 3'-end processing and splicing. , 2000, Genes & development.

[75]  C. Bodemer,et al.  Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome , 2000, Nature Genetics.

[76]  F. Morel,et al.  A novel and unusual case of chronic granulomatous disease in a child with a homozygous 36-bp deletion in the CYBA gene (A220) leading to the activation of a cryptic splice site in intron 4 , 2002, Human Genetics.

[77]  E. Vafiadaki,et al.  Mutation analysis in 57 unrelated patients with MPS II (Hunter’s disease) , 1998, Archives of disease in childhood.

[78]  M. Hentze,et al.  Abnormally spliced beta-globin mRNAs: a single point mutation generates transcripts sensitive and insensitive to nonsense-mediated mRNA decay. , 2002, Blood.

[79]  Y. Fujii‐Kuriyama,et al.  Aberrant splicing and missense mutations cause steroid 21-hydroxylase [P-450(C21)] deficiency in humans: possible gene conversion products. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[80]  J. Nicklas,et al.  Mutations that alter RNA splicing of the human HPRT gene: a review of the spectrum. , 1998, Mutation research.

[81]  Ravinder Singh,et al.  Sex lethal and U2 small nuclear ribonucleoprotein auxiliary factor (U2AF65) recognize polypyrimidine tracts using multiple modes of binding. , 2003, RNA.

[82]  G. Zambruno,et al.  Novel mutations in the LAMC2 gene in non-Herlitz junctional epidermolysis bullosa: effects on laminin-5 assembly, secretion, and deposition. , 2001, The Journal of investigative dermatology.

[83]  R. Krug,et al.  Identification of cis-acting intron and exon regions in influenza virus NS1 mRNA that inhibit splicing and cause the formation of aberrantly sedimenting presplicing complexes , 1992, Molecular and cellular biology.

[84]  S. Dimauro,et al.  Identification of three novel mutations in non-Ashkenazi Italian patients with muscle phosphofructokinase deficiency. , 1994, American journal of human genetics.

[85]  T. Hansen,et al.  Abnormal splicing of hepatocyte nuclear factor 1 alpha in maturity-onset diabetes of the young , 2002, Diabetologia.

[86]  D. Quon,et al.  Two mutations produce intron insertion in mRNA and elongated beta-subunit of human beta-hexosaminidase. , 1990, The Journal of biological chemistry.

[87]  H. Mandel,et al.  Profound biotinidase deficiency caused by a point mutation that creates a downstream cryptic 3' splice acceptor site within an exon of the human biotinidase gene. , 1997, Human molecular genetics.

[88]  Y. Takeshima,et al.  Heterogous Dystrophin mRNA Produced by a Novel Splice Acceptor Site Mutation in Intermediate Dystrophinopathy , 2003, Pediatric Research.

[89]  Jouni Uitto,et al.  Splicing modulation of integrin beta4 pre-mRNA carrying a branch point mutation underlies epidermolysis bullosa with pyloric atresia undergoing spontaneous amelioration with ageing. , 1999, Human molecular genetics.

[90]  M. Green,et al.  Pre-mRNA splicing of IgM exons M1 and M2 is directed by a juxtaposed splicing enhancer and inhibitor. , 1999, Genes & development.

[91]  T. Nakano,et al.  Genetic cause of a juvenile form of Sandhoff disease. Abnormal splicing of beta-hexosaminidase beta chain gene transcript due to a point mutation within intron 12. , 1989, The Journal of biological chemistry.

[92]  J. Barton,et al.  Hemojuvelin (HJV) mutations in persons of European, African‐American and Asian ancestry with adult onset haemochromatosis , 2004, British journal of haematology.

[93]  中村 こず枝 A novel single-base substitution(380C>T)that activates a 5-base downstream cryptic splice-acceptor site within exon 5 in almost all transcripts in the human mitochondrial acetoacetyl-CoA thiolase gene , 2002 .

[94]  H. Scheffer,et al.  Effects of keratin 14 ablation on the clinical and cellular phenotype in a kindred with recessive epidermolysis bullosa simplex. , 1996, The Journal of investigative dermatology.

[95]  M. Macek,et al.  Human β-Mannosidase cDNA Characterization and First Identification of a Mutation Associated with Human β-Mannosidosis , 1998 .

[96]  A. Tanae,et al.  Exon redefinition by a point mutation within exon 5 of the glucose-6-phosphatase gene is the major cause of glycogen storage disease type 1a in Japan. , 1995, American journal of human genetics.

[97]  J. Zschocke,et al.  Phenylketonuria mutations in Germany , 1999, Human Genetics.

[98]  D. Cooper,et al.  The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: Causes and consequences , 1992, Human Genetics.

[99]  H. Steingrimsdottir,et al.  Mutations which alter splicing in the human hypoxanthine-guanine phosphoribosyltransferase gene. , 1992, Nucleic acids research.

[100]  F. D. de Rooij,et al.  Systematic analysis of coproporphyrinogen oxidase gene defects in hereditary coproporphyria and mutation update , 1999, Human mutation.

[101]  P. Nürnberg,et al.  Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain. , 2000, American journal of human genetics.

[102]  Richard J. Thompson,et al.  A novel spice–site mutation in the γ subunit of the epithelial sodium channel gene in three pseudohypoaldosteronism type 1 families , 1996, Nature Genetics.

[103]  M. Moore,et al.  Evidence for a linear search in bimolecular 3' splice site AG selection. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[104]  S. Tonstad,et al.  Mutant transcripts of the LDL receptor gene: mRNA structure and quantity , 1999, Human mutation.

[105]  A. Tates,et al.  Molecular analysis of mutations affecting hprt mRNA splicing in human T‐lymphocytes in vivo , 1992, Environmental and molecular mutagenesis.

[106]  L. Kalaydjieva,et al.  Aberrant splicing of phenylalanine hydroxylase mRNA: the major cause for phenylketonuria in parts of southern Europe. , 1991, Genomics.

[107]  G Mortier,et al.  Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects , 2000, Human mutation.

[108]  X. Estivill,et al.  Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients , 2003, Journal of medical genetics.

[109]  R. Reed,et al.  The RNA splicing factor hSlu7 is required for correct 3′ splice-site choice , 1999, Nature.

[110]  N L Harris,et al.  Splice junctions, branch point sites, and exons: sequence statistics, identification, and applications to genome project. , 1990, Methods in enzymology.

[111]  J. Beggs,et al.  snRNA interactions at 5' and 3' splice sites monitored by photoactivated crosslinking in yeast spliceosomes. , 1995, RNA.

[112]  G. Tromp,et al.  Single base mutation in the pro alpha 2(I) collagen gene that causes efficient splicing of RNA from exon 27 to exon 29 and synthesis of a shortened but in-frame pro alpha 2(I) chain. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[113]  S. Weissman,et al.  Abnormally spliced messenger RNA in erythroid cells from patients with β + thalassemia and monkey cells expressing a cloned β +-thalassemic gene , 1982, Cell.

[114]  R. Hennekam,et al.  Parental somatic and germ-line mosaicism for a FBN2 mutation and analysis of FBN2 transcript levels in dermal fibroblasts. , 1997, American journal of human genetics.

[115]  André Rosenthal,et al.  Aberrant splicing of neural cell adhesion molecule L1 mRNA in a family with X–linked hydrocephalus , 1992, Nature Genetics.

[116]  X. Zhang,et al.  Functional and physical interaction between the yeast splicing factors Slu7 and Prp18. , 1997, Nucleic acids research.

[117]  M. Macek,et al.  Human beta-mannosidase cDNA characterization and first identification of a mutation associated with human beta-mannosidosis. , 1998, Human molecular genetics.

[118]  Eight new mutations of the phenylalanine hydroxylase gene in Italian patients with hyperphenylalaninemia , 1998, Human mutation.

[119]  Adrian R. Krainer,et al.  The essential pre-mRNA splicing factor SF2 influences 5′ splice site selection by activating proximal sites , 1990, Cell.

[120]  J. Valcárcel,et al.  Splicing Regulation at the Second Catalytic Step by Sex-lethal Involves 3′ Splice Site Recognition by SPF45 , 2002, Cell.

[121]  B. Lorenz,et al.  Tubby-like protein-1 mutations in autosomal recessive retinitis pigmentosa , 1998, The Lancet.

[122]  M. Jonkman,et al.  Features of epidermolysis bullosa simplex due to mutations in the ectodomain of type XVII collagen , 2004, The British journal of dermatology.

[123]  P. Czernichow,et al.  Syndromic short stature in patients with a germline mutation in the LIM homeobox LHX4. , 2001, American journal of human genetics.

[124]  Z. Tsuchihashi,et al.  Mutation and haplotype analyses of the Werner’s syndrome gene based on its genomic structure: genetic epidemiology in the Japanese population , 1997, Human Genetics.

[125]  D. Horn,et al.  Allelic heterogeneity in the COH1 gene explains clinical variability in Cohen syndrome. , 2004, American journal of human genetics.

[126]  Gene W. Yeo,et al.  Variation in sequence and organization of splicing regulatory elements in vertebrate genes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[127]  A. Krainer,et al.  General splicing factors SF2 and SC35 have equivalent activities in vitro, and both affect alternative 5' and 3' splice site selection. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[128]  M. Krempf,et al.  Intronic mutations outside of Alu-repeat-rich domains of the LDL receptor gene are a cause of familial hypercholesterolemia , 2002, Human Genetics.

[129]  Gene W. Yeo,et al.  Systematic Identification and Analysis of Exonic Splicing Silencers , 2004, Cell.

[130]  D. Farber,et al.  Defective RNA splicing resulting from a mutation in the cyclic guanosine monophosphate-phosphodiesterase beta-subunit gene. , 1998, Investigative ophthalmology & visual science.

[131]  J. Brunzell,et al.  A novel A-->G mutation in intron I of the hepatic lipase gene leads to alternative splicing resulting in enzyme deficiency. , 1996, Journal of lipid research.

[132]  K. Tanaka,et al.  Characterization of a splicing mutation in group A xeroderma pigmentosum. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[133]  Stephen M. Mount,et al.  A catalogue of splice junction sequences. , 1982, Nucleic acids research.

[134]  R. Gibbs,et al.  Identification of mutations leading to the Lesch-Nyhan syndrome by automated direct DNA sequencing of in vitro amplified cDNA. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[135]  Ravi Sachidanandam,et al.  Intrinsic differences between authentic and cryptic 5' splice sites. , 2003, Nucleic acids research.

[136]  P. Byers,et al.  Order of intron removal influences multiple splice outcomes, including a two-exon skip, in a COL5A1 acceptor-site mutation that results in abnormal pro-alpha1(V) N-propeptides and Ehlers-Danlos syndrome type I. , 2002, American journal of human genetics.

[137]  P. Sharp,et al.  Splicing of precursors to mRNAs by the spliceosomes , 1993 .

[138]  S E Antonarakis,et al.  beta-Thalassemia in American Blacks: novel mutations in the "TATA" box and an acceptor splice site. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[139]  F. Muntoni,et al.  Laminin alpha 2-chain gene mutations in two siblings presenting with limb-girdle muscular dystrophy. , 1998, Neuromuscular disorders : NMD.

[140]  H. Horvitz,et al.  Identification of three novel mutations in the gene for Cu Zn superoxide dismutase in patients with familial amyotrophic lateral sclerosis , 1995, Neuromuscular Disorders.

[141]  J. Alonso,et al.  Identification of 26 new constitutional RB1 gene mutations in Spanish, Colombian, and Cuban retinoblastoma patients , 2005, Human mutation.

[142]  R. Amann,et al.  Predictive Identification of Exonic Splicing Enhancers in Human Genes , 2022 .

[143]  X. Estivill,et al.  Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1. , 2000, Human molecular genetics.

[144]  T. Miyawaki,et al.  A 3′ splice site consensus sequence mutation in the intron 3 of the α-galactosidase a gene in a patient with Fabry disease , 1991, Japanese Journal of Human Genetics.

[145]  S. Tsuji,et al.  A novel exon mutation in the human beta-hexosaminidase beta subunit gene affects 3' splice site selection. , 1992, The Journal of biological chemistry.

[146]  J. Hardy,et al.  Aberrant splicing in the presenilin-1 intron 4 mutation causes presenile Alzheimer's disease by increased Abeta42 secretion. , 1999, Human molecular genetics.

[147]  J. Uitto,et al.  Cycloheximide facilitates the identification of aberrant transcripts resulting from a novel splice-site mutation in COL17A1 in a patient with generalized atrophic benign epidermolysis bullosa. , 1998, The Journal of investigative dermatology.

[148]  J. D. den Dunnen,et al.  Splicing mutations in DMD/BMD detected by RT-PCR/PTT: detection of a 19AA insertion in the cysteine rich domain of dystrophin compatible with BMD. , 1996, Journal of medical genetics.

[149]  W. Lissens,et al.  Molecular basis for type 1 antithrombin deficiency: identification of two novel point mutations and evidence for a de novo splice site mutation. , 1994, Blood.

[150]  A. Toubert,et al.  A novel HLA-B*39 allele (HLA-B*3916) due to a rare mutation causing cryptic splice site activation. , 2000, Human immunology.

[151]  J. Tolmie,et al.  The molecular basis of malonyl-CoA decarboxylase deficiency. , 1999, American journal of human genetics.

[152]  H. Pollmann,et al.  Mutational analysis of ectopic factor VIII transcripts from hemophilia A patients: identification of cryptic splice site, exon skipping and novel point mutations , 1997, Human Genetics.

[153]  A. Krainer,et al.  Listening to silence and understanding nonsense: exonic mutations that affect splicing , 2002, Nature Reviews Genetics.

[154]  C. H. Gross,et al.  Prp22, a DExH‐box RNA helicase, plays two distinct roles in yeast pre‐mRNA splicing , 1998, The EMBO journal.

[155]  Rolf Backofen,et al.  Widespread occurrence of alternative splicing at NAGNAG acceptors contributes to proteome plasticity , 2004, Nature Genetics.

[156]  M. Amaral,et al.  Cystic fibrosis patients with the 3272‐26A→G mutation have mild disease, leaky alternative mRNA splicing, and CFTR protein at the cell membrane , 1999, Human mutation.

[157]  H. Osaka,et al.  Novel acceptor splice site mutation in the invariant AG of intron 6 of alpha-galactosidase A gene, causing Fabry disease. Mutations in brief no. 146. Online. , 1998, Human mutation.

[158]  C. Shoulders,et al.  Genetic variation at a splicing branch point in intron 9 of the low density lipoprotein (LDL)-receptor gene: a rare mutation that disrupts mRNA splicing in a patient with familial hypercholesterolaemia and a common polymorphism. , 1996, Human molecular genetics.

[159]  P. Sharp,et al.  Three recognition events at the branch‐site adenine. , 1996, The EMBO journal.

[160]  J. G. Patton,et al.  Scanning from an independently specified branch point defines the 3′ splice site of mammalian introns , 1989, Nature.

[161]  K Rohrschneider,et al.  The 2588G-->C mutation in the ABCR gene is a mild frequent founder mutation in the Western European population and allows the classification of ABCR mutations in patients with Stargardt disease. , 1999, American journal of human genetics.

[162]  A. Beaudet,et al.  Heterogeneity of mutations in argininosuccinate synthetase causing human citrullinemia. , 1990, The Journal of biological chemistry.

[163]  M. Tanner,et al.  Absence of CD47 in protein 4.2-deficient hereditary spherocytosis in man: an interaction between the Rh complex and the band 3 complex. , 2002, Blood.

[164]  M. Hou,et al.  Molecular characterization of germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in Taiwan , 1999, Human Genetics.

[165]  B. Séraphin,et al.  The role of branchpoint‐3′ splice site spacing and interaction between intron terminal nucleotides in 3′ splice site selection in Saccharomyces cerevisiae , 1997, The EMBO journal.

[166]  Sara G. Becker-Catania,et al.  Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequences. , 1999, American journal of human genetics.

[167]  F. Muntoni,et al.  Laminin α2-chain gene mutations in two siblings presenting with limb-girdle muscular dystrophy , 1998, Neuromuscular Disorders.

[168]  P. Bosma,et al.  Splice-site mutations: a novel genetic mechanism of Crigler-Najjar syndrome type 1. , 1998, American journal of human genetics.

[169]  R. Gibbs,et al.  Multiplex DNA deletion detection and exon sequencing of the hypoxanthine phosphoribosyltransferase gene in Lesch-Nyhan families. , 1990, Genomics.

[170]  J. Gécz,et al.  Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. , 2004, American journal of human genetics.

[171]  G. Isshiki,et al.  Two mutations remote from an exon/intron junction in the β-hexosaminidase β-subunit gene affect 3’-splice site selection and cause Sandhoff disease , 1998, Human Genetics.

[172]  T. Dryja,et al.  Evaluation of the human arrestin gene in patients with retinitis pigmentosa and stationary night blindness. , 1998, Investigative ophthalmology & visual science.

[173]  D. Evans,et al.  A novel TP53 splicing mutation in a Li-Fraumeni syndrome family: a patient with Wilms' tumour is not a mutation carrier. , 1998, British Journal of Cancer.

[174]  J. Královičová,et al.  Branch site haplotypes that control alternative splicing. , 2004, Human molecular genetics.

[175]  T. Gilliam,et al.  Identification and analysis of mutations in the Wilson disease gene (ATP7B): population frequencies, genotype-phenotype correlation, and functional analyses. , 1997, American journal of human genetics.

[176]  D. Kastner,et al.  The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. , 2001, American journal of human genetics.

[177]  Y. Eto,et al.  Single exon mutation in arylsulfatase A gene has two effects: loss of enzyme activity and aberrant splicing , 1994, Human Genetics.

[178]  J. Genest,et al.  Familial hypercholesterolemia. Acceptor splice site (G-->C) mutation in intron 7 of the LDL-R gene: alternate RNA editing causes exon 8 skipping or a premature stop codon in exon 8. LDL-R(Honduras-1) [LDL-R1061(-1) G-->C]. , 1999, Atherosclerosis.

[179]  F. Pociot,et al.  Variation in antiviral 2',5'-oligoadenylate synthetase (2'5'AS) enzyme activity is controlled by a single-nucleotide polymorphism at a splice-acceptor site in the OAS1 gene. , 2005, American journal of human genetics.

[180]  T. Lerner,et al.  Spectrum of mutations in the Batten disease gene, CLN3. , 1997, American journal of human genetics.

[181]  C. W. Fisher,et al.  A 17-bp insertion and a Phe215----Cys missense mutation in the dihydrolipoyl transacylase (E2) mRNA from a thiamine-responsive maple syrup urine disease patient WG-34. , 1991, Biochemical and biophysical research communications.

[182]  L. Chasin,et al.  Computational definition of sequence motifs governing constitutive exon splicing. , 2004, Genes & development.

[183]  C. Wadelius,et al.  New domains of neural cell-adhesion molecule L1 implicated in X-linked hydrocephalus and MASA syndrome. , 1995, American journal of human genetics.

[184]  J. Tam,et al.  A novel function for the U2AF 65 splicing factor in promoting pre‐mRNA 3′‐end processing , 2002, EMBO reports.